BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8298)

  • 1. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M; Hopf R; Keller M
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conservative medical treatment of hypertrophic myocardiopathies].
    Kaltenbach M; Hopf R
    Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 11. [beta-Blocking therapy in obstructive hypertrophic cardiomyopathy. Long term results (author's transl)].
    Fancini P; Cataldo G; Mascarello M; Pria B; Figini A; Borghi A; Austoni P; Bonara D; Rovelli F
    G Ital Cardiol; 1980; 10(6):657-67. PubMed ID: 6109683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of long-term verapamil treatment of patients with hypertrophic cardiomyopathy].
    Dabrowski M; Michalak E; Maurin A; Rydlewska-Sadowska W; Ruzyłło W
    Kardiol Pol; 1989; 32 Suppl 2():6-16. PubMed ID: 2634154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M; Hopf R
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
    Wagner JA; Sax FL; Weisman HF; Porterfield J; McIntosh C; Weisfeldt ML; Snyder SH; Epstein SE
    N Engl J Med; 1989 Mar; 320(12):755-61. PubMed ID: 2537929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex hemodynamic analysis of left ventricular systole in hypertrophic cardiopathy--clinical implications].
    Dabrowski M; Górecka B; Witkowski A; Ruzyłło W
    Kardiol Pol; 1990; 33(5):288-302. PubMed ID: 2074625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic obstructive cardiomyopathy. The importance of echography for diagnosis (author's transl)].
    Heni HE
    MMW Munch Med Wochenschr; 1980 Feb; 122(8):271-4. PubMed ID: 6102736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug treatment of hypertrophic cardiomyopathy].
    Hirzel HO
    Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of hypertrophic cardiomyopathy by ECG gated cardiac computed tomography (author's transl)].
    Takeuchi K; Tanaka C; Oku H; Ikuno Y; Yoshimura T; Kotsumi K; Inoue E; Minamikawa H; Komatsu H; Yamashita A; Furukawa K; Nishimoto M; Kawai S; Sakaguchi K
    J Cardiogr; 1981 Sep; 11(3):847-58. PubMed ID: 7198673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.